Loading company…
Cambridge-based biotechnology company developing novel drugs to diagnose and treat human cancers.
TransMolecular, Inc. is a biotechnology company based in Massachusetts, US, with a Cambridge headquarters. It develops and commercializes novel, proprietary drugs to diagnose and treat human cancers that have inadequate pharmaceutical alternatives. The company is at the Series C stage and operates in the healthcare sector.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in